您的位置: 首页 > 农业专利 > 详情页

ANTICORPS AYANT UNE MEILLEURE ACTIVITE CYTOTOXIQUE CELLULAIRE DEPENDANT DES ANTICORPS ET LEURS PROCEDES DE PRODUCTION ET LEUR UTILISATION
专利权人:
GENZYME CORPORATION;GTC BIOTHERAPEUTICS, INC.
发明人:
SCHINDLER, DANIEL,MEADE, HARRY M.,EDMUNDS, TIMOTHY,MCPHERSON, JOHN
申请号:
CA2626542
公开号:
CA2626542C
申请日:
2006.10.23
申请国别(地区):
CA
年份:
2018
代理人:
摘要:
The invention relates, in part, to antibodies with increased ADCC activity.Methods of producing such antibodies are also provided. The antibodies of theinvention are produced in mammary epithelial cells, such as those in a non-human transgenic animal engineered to express and secrete the antibody in itsmilk. The antibodies or compositions comprising the antibodies can be used totreat disease in which ADCC activity provides a benefit. In one embodiment,therefore, the antibodies or compositions comprising the antibodies can beused to treat cancer, lymphoproliferative disease or autoimmune disease.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充